期刊文献+

PTEN基因转染联合奥沙利对胆管癌细胞生长的影响 被引量:1

Inhibitory effects of PTEN gene transfection combined with L-OHP on proliferation of human cholangiocarcinoma cells
下载PDF
导出
摘要 目的:观察脂质体介导PTEN基因转染人胆管癌细胞(QBC939),联合化疗药物奥沙利铂(L—OHP)对胆管癌细胞生长的影响,探索人类胆管癌的生物治疗方法。方法:将携带PTEN基因的真核表达载体pBP-PTEN和不含该基因的空载体转染胆管癌QBC939细胞,嘌呤霉素抗性筛选克隆、扩增培养,S-P免疫组化法检测转染前后PTEN阳性表达率。实验分组为QBC939、QBC+L-OHP、PTEN-QBC和PTEN+L-OHP 4组,以MTT法检测癌细胞生长活性,透射电镜扫描观察转染前后及联合奥沙利铂后细胞的超微结构变化,流式细胞仪分析转染前后细胞周期变化和凋亡情况,体外细胞侵袭力抑制试验观察转染及用药前后细胞侵袭力的变化。结果:PTEN基因转染后QBC939细胞稳定表达、PTEN阳性表达率升高(P<0.05);基因转染后肿瘤细胞活性下降(P<0.05);细胞周期G1~S期抑制、细胞凋亡率增加(P<0.01);透射电镜下显示细胞较成熟、分化好、线粒体增多;细胞侵袭力明显抑制(P<0.05),其中以PTEN+L-OHP抑制作用最强,L-OHP抑制作用次之。结论:PTEN基因转染生物治疗联合奥沙利铂化疗对人胆管癌细胞生长具有显著的抑制作用。 Objective: To investigate the inhibitory effects of PTEN gene transfection combined with L-OHP on human cholangiocarcinoma cell line, QBC939, providing a new method for gene therapy of human biliary duct carcinoma. Methods: A eukaryotic expression vector containing PTEN gene was transfected into human QBC939 cells under mediation of lipofectamine and positive cell clones were selected and amplified. Expression of PTEN gene was detected by immunohistochemistry. MTT test was used to determine the in vitro activity of cells, electron microscope was applied to observe cell uhrastructure, and flow cytometry was used for determining the cell cycle and apoptosis. In vitro test was used to study the invasive ability of cells before and after treatment. Results: After transfected with PTEN gene, QBC939 cells had a higher expression of PTEN gene ( P 〈 0.05 ), a decreased activity ( P 〈 0.05 ), an arrest of G1 -S phase, and an increased apoptotic rate (P 〈0.01 ). Electron microscope showed that maturity of cells and increased well-differentiated mitochondria. The aggressiveness of the cells was obviously inhibited (P 〈 0.05 ). Conclusion : PTEN gene transfection combined with L-OHP has obvious inhibitory effect on cholangiocarcinoma cell line in vitro.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2006年第3期171-175,共5页 Chinese Journal of Cancer Biotherapy
基金 云南省卫生厅项目
关键词 PTEN基因 胆管癌细胞 细胞生长 奥沙利铂 PTEN gene cholangiocarcinoma cell cell growth oxlipatine
  • 引文网络
  • 相关文献

参考文献12

  • 1Reed DN Jr,Vitale GC,Martin R,et al.Bile duct carcinoma:trends in treatment in the ninties[J].Am Surg,2000,66 (8):711-714.
  • 2Raymond E,Faivre S,Chaney S,et al.Cellular and molecular pharmacology of Oxalipatin[J].Mol Cancer Ther,2002,1 (3)227-235.
  • 3李志强,袁先厚.PTEN基因与脑胶质瘤[J].国外医学(遗传学分册),2000,23(3):150-152. 被引量:5
  • 4谷化平,尚培中,周翠玲.胆管癌中PTEN和p16抑癌基因蛋白的表达及其临床意义[J].中国普通外科杂志,2004,13(2):101-103. 被引量:14
  • 5Gebbia V,Majello E,Testa A,et al.Treatment of adavenced adenocarcinoma of the exocrin pancreas and the gallbladder with 5-FU,hight dose levofolince acid and oral hydroxyurea on weekly schedule results of multicenter study of the sounthem Italy incology group[J].Cancer,1996,78(6):1300-1307.
  • 6Tanaka M,Grossman HB.In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth,downregulates phosphorylated Akt,and increases sensitivity todoxorubin[J].Gene Ther,2003,10 (19):1636-1642.
  • 7Stewart AL,Mhashilkar AM,Yang XH,et al.PI3K blockade by Ad-PTEN inhibits invasion and induces apoptosis in radial growth phase and metastatic melanoma cell[J].Mol Med,2002,8 (8):451-461.
  • 8Zhong H,Chiles K,Feldser D,et al.Modulation of hypoxia-inducible factor lalpha expression by theepidermal growth factor/phosphatidylinositol3-kinase/ PTEN/AKT/FRAP pathway in human prostate cancer cells:implications for tumor angiogenesis and therapeutics[J].Cancer Res,2000,60 (6):1541-1545.
  • 9Brunet A,Bouni A,Zigmond MJ,et al.Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor[J].Cell,1999,96(6):857-868.
  • 10Freeman DJ,Li AG,Wei G,et al.PTEN tumor suppressor regulates P53 protein levels and activity through phosphatase-dependent and independent mechanisms[J].Cancer Cell,2003,3 (2):117-130.

二级参考文献17

  • 1朱如玮,刘振延.新型抑癌基因 p16[J].肿瘤,1997,17(3):178-179. 被引量:12
  • 2LiJetal.Science,1997,275:1943-1947.
  • 3SteckPAetal.NatGenet,1997,15:356-363.
  • 4LiDMetal.CancerRes,1997,57:2124-2129.
  • 5FurnariFBetal.ProcNatlAcadSciUSA,1997,94:12479-12484.
  • 6MyersMPetal.ProcNatlAcadSciUSA,1997,94:9052-9057.
  • 7MaierDetal.Oncogene,1998,16(24):3331-3335.
  • 8WangSIetal.CancerRes,1997,57:4183-4186.
  • 9AhmedRasheedBKetal.CancerRes,1997,57:4187-4190.
  • 10JohmaYetal.JNeuropatholExpNeurol,1998,57(7):684-689.

共引文献16

同被引文献4

引证文献1

二级引证文献3

;
使用帮助 返回顶部